499 related articles for article (PubMed ID: 32094077)
41. New Treatment Option for Chronic Obstructive Pulmonary Disease: Two Long-Acting Bronchodilators in a Single Metered-Dose Inhaler.
Self TH; Ellingson S
Am J Med; 2017 Nov; 130(11):1251-1254. PubMed ID: 28757318
[TBL] [Abstract][Full Text] [Related]
42. Human coronavirus 229E binds to CD13 in rafts and enters the cell through caveolae.
Nomura R; Kiyota A; Suzaki E; Kataoka K; Ohe Y; Miyamoto K; Senda T; Fujimoto T
J Virol; 2004 Aug; 78(16):8701-8. PubMed ID: 15280478
[TBL] [Abstract][Full Text] [Related]
43. Low-Dose Carbon Monoxide Inhibits Rhinovirus Replication in Human Alveolar and Airway Epithelial Cells.
Deng X; Yasuda H; Sasaki T; Yamaya M
Tohoku J Exp Med; 2019 Apr; 247(4):215-222. PubMed ID: 30971638
[TBL] [Abstract][Full Text] [Related]
44. Spotlight on glycopyrronium/formoterol fumarate inhalation aerosol in the management of COPD: design, development, and place in therapy.
Dhungana S; Criner GJ
Int J Chron Obstruct Pulmon Dis; 2017; 12():2307-2312. PubMed ID: 28814858
[TBL] [Abstract][Full Text] [Related]
45. Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts.
Spoelstra FM; Postma DS; Hovenga H; Noordhoek JA; Kauffman HF
Thorax; 2002 Mar; 57(3):237-41. PubMed ID: 11867828
[TBL] [Abstract][Full Text] [Related]
46. Ambroxol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells.
Yamaya M; Nishimura H; Nadine LK; Ota C; Kubo H; Nagatomi R
Arch Pharm Res; 2014 Apr; 37(4):520-9. PubMed ID: 23856970
[TBL] [Abstract][Full Text] [Related]
47. Cells of human aminopeptidase N (CD13) transgenic mice are infected by human coronavirus-229E in vitro, but not in vivo.
Wentworth DE; Tresnan DB; Turner BC; Lerman IR; Bullis B; Hemmila EM; Levis R; Shapiro LH; Holmes KV
Virology; 2005 May; 335(2):185-97. PubMed ID: 15840518
[TBL] [Abstract][Full Text] [Related]
48. Long-acting β2-adrenoreceptor agonists suppress type 1 interferon expression in human plasmacytoid dendritic cells via epigenetic regulation.
Kuo CH; Yang SN; Tsai YG; Hsieh CC; Liao WT; Chen LC; Lee MS; Kuo HF; Lin CH; Hung CH
Pulm Pharmacol Ther; 2018 Feb; 48():37-45. PubMed ID: 28987803
[TBL] [Abstract][Full Text] [Related]
49. Clarithromycin decreases rhinovirus replication and cytokine production in nasal epithelial cells from subjects with bronchial asthma: effects on IL-6, IL-8 and IL-33.
Yamaya M; Nomura K; Arakawa K; Sugawara M; Deng X; Lusamba Kalonji N; Nishimura H; Yamada M; Nagatomi R; Kawase T
Arch Pharm Res; 2020 May; 43(5):526-539. PubMed ID: 28861755
[TBL] [Abstract][Full Text] [Related]
50. Effect of budesonide and formoterol on IL-6 and IL-8 release from primary bronchial epithelial cells.
Strandberg K; Palmberg L; Larsson K
J Asthma; 2008 Apr; 45(3):201-3. PubMed ID: 18415826
[TBL] [Abstract][Full Text] [Related]
51. The NF-κB-dependent and -independent transcriptome and chromatin landscapes of human coronavirus 229E-infected cells.
Poppe M; Wittig S; Jurida L; Bartkuhn M; Wilhelm J; Müller H; Beuerlein K; Karl N; Bhuju S; Ziebuhr J; Schmitz ML; Kracht M
PLoS Pathog; 2017 Mar; 13(3):e1006286. PubMed ID: 28355270
[TBL] [Abstract][Full Text] [Related]
52. Budesonide promotes airway epithelial barrier integrity following double-stranded RNA challenge.
Rimmer C; Hetelekides S; Eliseeva SI; Georas SN; Veazey JM
PLoS One; 2021; 16(12):e0260706. PubMed ID: 34871316
[TBL] [Abstract][Full Text] [Related]
53. Cytokine-induced loss of glucocorticoid function: effect of kinase inhibitors, long-acting β(2)-adrenoceptor [corrected] agonist and glucocorticoid receptor ligands.
Rider CF; Shah S; Miller-Larsson A; Giembycz MA; Newton R
PLoS One; 2015; 10(1):e0116773. PubMed ID: 25625944
[TBL] [Abstract][Full Text] [Related]
54. TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium.
Bertram S; Dijkman R; Habjan M; Heurich A; Gierer S; Glowacka I; Welsch K; Winkler M; Schneider H; Hofmann-Winkler H; Thiel V; Pöhlmann S
J Virol; 2013 Jun; 87(11):6150-60. PubMed ID: 23536651
[TBL] [Abstract][Full Text] [Related]
55. Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells.
Korn SH; Jerre A; Brattsand R
Eur Respir J; 2001 Jun; 17(6):1070-7. PubMed ID: 11491146
[TBL] [Abstract][Full Text] [Related]
56. Glycopyrronium/Formoterol: A Review in COPD.
Al-Salama ZT; Frampton JE
Drugs; 2019 Sep; 79(13):1455-1466. PubMed ID: 31468315
[TBL] [Abstract][Full Text] [Related]
57. Hochu-ekki-to inhibits rhinovirus infection in human tracheal epithelial cells.
Yamaya M; Sasaki T; Yasuda H; Inoue D; Suzuki T; Asada M; Yoshida M; Seki T; Iwasaki K; Nishimura H; Nakayama K
Br J Pharmacol; 2007 Mar; 150(6):702-10. PubMed ID: 17310142
[TBL] [Abstract][Full Text] [Related]
58. α and β catalytic subunits of cAMP-dependent protein kinase regulate formoterol-induced inflammatory gene expression changes in human bronchial epithelial cells.
Hamed O; Joshi R; Mostafa MM; Giembycz MA
Br J Pharmacol; 2022 Sep; 179(18):4593-4614. PubMed ID: 35735057
[TBL] [Abstract][Full Text] [Related]
59. Synergistic suppression of Poly(I:C)-induced CCL3 by a corticosteroid and a long acting β2 agonist in nasal epithelial cells.
Tanaka S; Tamari M; Nakayama T; Ishii H; Hatsushika K; Hayashi A; Watanabe H; Kanai M; Osano M; Yonaga T; Tomita K; Fujieda S; Sakuma Y; Shiono O; Ishitoya J; Masuyama K; Hirota T
Allergol Int; 2015 Apr; 64(2):196-9. PubMed ID: 25838100
[No Abstract] [Full Text] [Related]
60. Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study.
Ichinose M; Fukushima Y; Inoue Y; Hataji O; Ferguson GT; Rabe KF; Hayashi N; Okada H; Takikawa M; Bourne E; Ballal S; DeAngelis K; Aurivillius M; Dorinsky P; Reisner C
Int J Chron Obstruct Pulmon Dis; 2019; 14():2979-2991. PubMed ID: 31920295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
